3 Reasons Clinics Are Switching to STAAR GPS™

3 Reasons Clinics Are Switching to STAAR GPS™

By STAAR LABS | May 2025

The weight loss industry is evolving.

Patients want results. Providers want safe, compliant tools.

STAAR GPS™ delivers both.

Here’s why leading clinics are abandoning GLP-1 monotherapy and adopting the STAAR GPS Protocol™ — a smarter, multi-pathway approach that addresses today’s clinical realities.

✅ Reason 1: GLP-1s Alone Just Don’t Cut It

Yes, semaglutide, dulaglutide, and liraglutide have transformed weight loss care. But they’re also incomplete on their own:

• Amylin signaling (satiety, glucose regulation) is ignored

• Muscle loss risk increases with rapid weight loss

• Patients plateau early, often within 8–12 weeks

• GIP support is nonexistent — yet crucial to long-term metabolic success
  

STAAR GPS™ solves this.

By combining a GLP-1 with pramlintide + SLM+, GPS protocols re-activate stalled weight loss pathways and amplify results with less rebound risk.

🧠 Reminder: Liraglutide and Dulaglutide = Suboptimal Alone

Whether you’re prescribing a branded GLP-1 or a compliant compounded option, clinical outcomes are consistently enhanced when:

1. Pramlintide (synthetic amylin) is added to regulate post-meal glucose and prolong satiety

2. SLM+ is layered in to boost insulin sensitivity, mimic GIP activity, and protect lean mass

No matter the GLP-1 — commercial, compounded, or manufactured — you can apply the GPS Protocol™ to improve results.

✅ Reason 2: It’s Legally Safe and Medically Sound

The STAAR GPS Protocol™ was built for today’s regulatory environment:

• GLP-1 + pramlintide are prescribed by licensed medical professionals

• SLM+ is a GMP-certified nutraceutical formulated for metabolic support

• No use of banned or restricted GLP-1s

• Fully compliant with DSHEA, FDA, and FTC guidance
  
  Providers retain prescribing control.

Patients get structured care.

Everyone stays protected.

✅ Reason 3: It’s Built for Real-World Clinics

GLP-1 shortages, semaglutide bans, and high brand-name prices have created chaos for clinics.

STAAR GPS™ gives you a scalable, dependable protocol that works whether you’re:

• Running a boutique weight loss clinic

• Transitioning from compounded semaglutide and tirzepatide

• Working with underserved or cost-conscious patients

The model works with your existing infrastructure — not against it.

📦 Protocol Options for Every Patient

• GPS-L™: Liraglutide + Pramlintide + SLM+

• GPS-D™: Dulaglutide + Pramlintide + SLM+

• Custom GLP-1 + GPS Model: Patients already on semaglutide, tirzepatide, or compounded options can add SLM+ + Pramlintide to convert to a full GPS-compatible protocol.

📍 Note: STAAR LABS does not provide pramlintide or GLP-1 medications. These must be prescribed and fulfilled by your licensed provider or pharmacy.

💬 Clinic Testimonial

“We were frustrated with semaglutide shortages and didn’t know where to turn. With GPS-L and GPS-D, we now offer safer, cost-effective options that keep our patients progressing.”

— L. Caldwell, NP | Integrative Wellness Clinic

⚠️ Disclaimers

Medical Disclaimer: This content is provided for educational purposes only and is not intended as medical advice. The STAAR GPS Protocol™ must be prescribed and managed by a licensed healthcare provider. Individual results may vary.

Supplement Disclaimer: SLM+ by STAAR LABS is a dietary supplement. These statements have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease.

Compliance Note: STAAR LABS does not sell or distribute prescription medications. All pharmaceutical components of the GPS Protocol™ are provided through licensed healthcare providers and regulated compounding pharmacies.

Research Disclosure: STAAR LABS collaborates with clinics and licensed professionals to develop innovative metabolic health strategies that integrate pharmaceutical and nutraceutical interventions.